Suppr超能文献

与拉莫三嗪给药相关的致命性中毒性表皮坏死松解症。

Fatal toxic epidermal necrolysis related to lamotrigine administration.

作者信息

Page R L, O'Neil M G, Yarbrough D R, Conradi S

机构信息

Department of Pharmacy Services, Medical University of South Carolina, Charleston 29425, USA.

出版信息

Pharmacotherapy. 1998 Mar-Apr;18(2):392-8.

PMID:9545161
Abstract

Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) are severe life-threatening dermatologic conditions. To date, eight cases of TEN and one of SJS related to lamotrigine administration have been reported in the literature. Most patients were also taking concomitant valproic acid. It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamotrigine levels, or perhaps alter the drug's metabolism, resulting in accumulation of a toxic intermediate metabolite. Ultimately, this may possibly predispose a patient to increased dermatologic reactions, including TEN. A 54-year-old man developed TEN 4 weeks after beginning lamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor. The patient had also been taking concomitant allopurinol and captopril for more than 4 years with no complications, and valproic acid 3 months before the cutaneous event. Despite aggressive intensive care management, the patient died 17 days from the onset of symptoms due to multiple organ failure. Administration of lamotrigine, especially in combination with valproic acid, may lead to the development of TEN.

摘要

中毒性表皮坏死松解症(TEN)和史蒂文斯-约翰逊综合征(SJS)是严重危及生命的皮肤病。迄今为止,文献中已报道8例与服用拉莫三嗪相关的TEN病例和1例SJS病例。大多数患者同时还服用丙戊酸。据推测,丙戊酸可能会干扰拉莫三嗪的葡萄糖醛酸化,导致血清拉莫三嗪水平升高,或者可能改变药物的代谢,导致有毒中间代谢产物的蓄积。最终,这可能使患者更容易出现包括TEN在内的皮肤反应增加。一名54岁男性在开始服用拉莫三嗪治疗与多形性胶质母细胞瘤相关的复杂部分性癫痫发作4周后发生了TEN。该患者同时服用别嘌醇和卡托普利超过4年且无并发症,在皮肤事件发生前3个月开始服用丙戊酸。尽管进行了积极的重症监护治疗,但患者在症状出现17天后因多器官衰竭死亡。服用拉莫三嗪,尤其是与丙戊酸联合使用时,可能会导致TEN的发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验